(S-028.1912-12)
The dose escalation in days 16-30 is designed to reinforce the signaling pathways activated in Phase 1
Brief history of anti-seizure drug development
Who Should Not Undergo This Procedure Based on current clinical understanding, IV glutathione infusions are generally not appropriate for: Individuals who are pregnant or breastfeeding Patients with a history of kidney or liver disease Those with a known allergy to glutathione, ascorbic acid (Vitamin C), or any other component of the infusion Individuals with certain autoimmune or haematological conditions these should be assessed and discussed with a doctor Comparing IV Glutathione to Evidence-Based Skin-Brightening Treatments For patients with concerns about skin tone, hyperpigmentation, melasma, post-inflammatory hyperpigmentation (PIH), or solar lentigines, a range of treatments with a more established evidence base are available in Singapore

In a statement to NPR, a spokesperson for the Department of Health and Human Services said all the committee members have "undergone an ethics and vetting process," and the agency is "committed to robust, transparent discussions about the products." While the panel is tasked with making recommendations, FDA leadership has the final say on what happens